Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Cell-mediated Immune Responses01:40

Cell-mediated Immune Responses

Overview
Cross-reactivity00:42

Cross-reactivity

Overview
Hypersensitivities01:30

Hypersensitivities

Hypersensitivity, also known as a hypersensitivity reaction or allergic reaction, is a condition where the body's immune system reacts abnormally to a foreign substance. Such substances, that cause hypersensitivity are referred to as an allergen, could be something typically harmless to most people, like pollen or certain foods.
Types of Hypersensitivities
Hypersensitivity reactions are categorized into four types: Type 1, Type 2, Type 3, and Type 4. Each type has a distinct mechanism...
Tumor Immunotherapy01:27

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
Drug Toxicity: Allergic Reactions01:30

Drug Toxicity: Allergic Reactions

Drug-related allergies are immune-mediated responses triggered by the administration of pharmacological agents. These hypersensitivity reactions are classified based on the immune mechanisms involved. The four primary types—Type I, II, III, and IV—are mediated by different immunological pathways and exhibit distinct clinical manifestations.Type I Hypersensitivity/ IgE-Mediated Reactions: Immunoglobulin E (IgE) immediately mediates Type I hypersensitivity reactions. Upon initial exposure to a...
Allergic Reactions: Anaphylaxis01:30

Allergic Reactions: Anaphylaxis

Anaphylaxis is a severe, life-threatening hypersensitivity reaction mediated by Immunoglobulin E (IgE) antibodies. When IgE binds to allergens, it triggers the release of mediators– histamine, leukotrienes, and prostaglandins from mast cells and basophils. These mediators cause vasodilation, edema, and inflammation, leading to various symptoms.The primary allergens causing anaphylaxis include food items (e.g., peanuts, shellfish), drugs (e.g., penicillin, asparaginase, corticotropin, heparin),...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Upper and lower airways response to tezepelumab in asthma patients with / without comorbid nasal polyposis: a 6-months reallife perspective.

Rhinology·2026
Same author

Tezepelumab for severe asthma: elevating current practice to recognize epithelial driven profiles.

Respiratory research·2024
Same author

Chronic rhinosinusitis with nasal polyposis and biological agents: the ARIA-ITALY survey.

European annals of allergy and clinical immunology·2024
Same author

A hierarchical cluster analysis of the psycological impact of the COVID-19 pandemic on Italian severe asthma patients.

The Journal of asthma : official journal of the Association for the Care of Asthma·2023
Same author

Allergic rhinitis and COVID-19: friends or foes?

European annals of allergy and clinical immunology·2021
Same author

Biologics and global burden of asthma: A worldwide portrait and a call for action.

The World Allergy Organization journal·2021

Related Experiment Video

Updated: Jul 12, 2026

Intralymphatic Immunotherapy and Vaccination in Mice
07:33

Intralymphatic Immunotherapy and Vaccination in Mice

Published on: February 2, 2014

Safety of specific immunotherapy

L Andri, G Senna, P Mezzelani

    Annals of Allergy
    |March 1, 1994
    PubMed
    Summary

    No abstract available in PubMed .

    More Related Videos

    Generation of CAR T Cells for Adoptive Therapy in the Context of Glioblastoma Standard of Care
    12:55

    Generation of CAR T Cells for Adoptive Therapy in the Context of Glioblastoma Standard of Care

    Published on: February 16, 2015

    Development of Stem Cell-derived Antigen-specific Regulatory T Cells Against Autoimmunity
    10:10

    Development of Stem Cell-derived Antigen-specific Regulatory T Cells Against Autoimmunity

    Published on: November 8, 2016

    Related Experiment Videos

    Last Updated: Jul 12, 2026

    Intralymphatic Immunotherapy and Vaccination in Mice
    07:33

    Intralymphatic Immunotherapy and Vaccination in Mice

    Published on: February 2, 2014

    Generation of CAR T Cells for Adoptive Therapy in the Context of Glioblastoma Standard of Care
    12:55

    Generation of CAR T Cells for Adoptive Therapy in the Context of Glioblastoma Standard of Care

    Published on: February 16, 2015

    Development of Stem Cell-derived Antigen-specific Regulatory T Cells Against Autoimmunity
    10:10

    Development of Stem Cell-derived Antigen-specific Regulatory T Cells Against Autoimmunity

    Published on: November 8, 2016